Logistics Articles
-
EU Gynecology Market: Incontinence Sling Market Fading, Opportunities Favor Lasers
10/11/2016
As women become more comfortable discussing sexual health with medical professionals, the market garners greater attention and receives more funding. Increases in potential patients seeking treatment will correlate with more liberal cultural environments and countries with supportive reimbursement and legislation.
-
Targeting Unmet Medical Needs From The Ground Up: A Tutorial
10/5/2016
To grasp the opportunities offered by underserved patient populations, medtechs must invest in risk by embedding resources in emerging market regions, locate and hire local talent, and break barriers related to intellectual property, local regulations, and policies.
-
TAVR: Will It Render Open-Heart Valve Replacement Surgery Obsolete?
9/28/2016
I spoke with Craig Thompson, MD, SVP/CMO of Boston Scientific’s Interventional Cardiology unit, about TAVR costs, benefits, and market drivers, as well as Boston Scientific’s Lotus valve system.
-
The Future Of Surgical Care In Emerging Markets
9/21/2016
If, as most believe, the future of the medical device industry will be determined by emerging markets, manufacturers need to embrace the idea of needs-driven local innovation for unmet medical needs.
-
6 Ways Medtech Can Give Back To The Community
9/16/2016
As part of the outsourcing and offshoring community, we collectively take a lot from local communities, and often forget what enables us to reap such financial and strategic benefits. Giving back to the communities in which we live and work should be a cornerstone of the outsourcing/offshoring relationship.
-
EU Hearing Device Market Faces Mounting Pricing Pressure
9/14/2016
The European market for hearing devices has experienced significant growth in recent years. In 2015, the market was valued at just over €7.2 billion. Included in our analysis are the markets for hearing aids, hearing aid batteries, cochlear implants, and bone-anchored hearing aids.
-
How Device Manufacturers Can Evolve Alongside The Shifting Provider And Payer Landscape
9/7/2016
Historically, fee-for-service arrangements allowed hospital facilities to bill costs and receive payments under various contracted reimbursement scenarios, like diagnosis-related groups (DRGs) or fee schedules that transferred most of the risk to the payer. Now, as value-based reimbursement becomes a more pervasive reimbursement mechanism, every care component cost (from paper clips and medical personnel to drugs and devices) is a target for cost management.
-
Capitalizing On Surgical Oncology's Device Innovation Opportunities
9/2/2016
Considering the direction of cutting-edge medtech innovations, I think surgical oncology will see a wave of innovation in areas specifically focused on non-invasive preventive and diagnostic screenings, accuracy of tumor excision, and smart implants.
-
3 Urgent Issues Facing The Diagnostic Market
8/31/2016
While the American Association of Clinical Chemistry event’s 68th installment featured various brilliant minds and plenty of discussion regarding industry trends, new product launches, and retooled service offerings from medical diagnostics makers, there were three consistent themes that resonated throughout.
-
How Roche Approaches Home Monitoring With New Point-of-Care Device
8/24/2016
Beyond addressing an unmet medical need, diagnostics device makers serving the home point-of-care (POC) market must satisfy both the care provider and the patient if a product is to succeed. Add to that the challenge of keeping pace with the evolution of telehealth and mobile health platforms, and the uncertainty of new technology — specifically, that it doesn’t always deliver on its promise of a trouble-free solution.